Dexfenfluramine and neurotoxicity. Author's repliesBAUMGARTEN, G; GARATTINI, S; LEFEBVRE, P et al.Lancet (British edition). 1992, Vol 339, Num 8789, pp 359-361, issn 0140-6736Article

Measurement of human brain dexfenfluramine concentration by 19F magnetic resonance spectroscopyCHRISTENSEN, J. D; YURGELUN-TODD, D. A; BABB, S. M et al.Brain research. 1999, Vol 834, Num 1-2, pp 1-5, issn 0006-8993Article

Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin releaseYOUNG, A. H; RUE, J; ODONTIADIS, J et al.Psychopharmacologia. 1998, Vol 136, Num 2, pp 198-200, issn 0033-3158Article

Anorexigènes (suite) = Anorexigens (continuation)La Revue Prescrire. 1998, Vol 18, Num 182, issn 0247-7750, p. 196Article

Valvulopathies dues aux anorexigènes (suite) = Heart valve abnormalities induced by anorexigens (continuation)La Revue Prescrire. 1999, Vol 19, Num 193, pp 204-205, issn 0247-7750Article

Effects of amphetamine, dexfenfluramine, and diazepam on responding during extinction in nonhuman primatesFOLTIN, Richard W.Pharmacology, biochemistry and behavior. 2004, Vol 79, Num 2, pp 325-330, issn 0091-3057, 6 p.Article

Effects of oleoyl-estrone with dexfenfluramine, sibutramine or phentermine on overweight ratsFERRER-LORENTE, Raquel; CABOT, Cristina; FERNANDEZ-LOPEZ, José-Antonio et al.European journal of pharmacology. 2005, Vol 513, Num 3, pp 243-248, issn 0014-2999, 6 p.Article

Dexfenfluramine does not worsen but moderates progression of chronic hypoxia-induced pulmonary hypertensionROCHEFORT, Gaël Y; LEMAIRE, Marie-Christine; EDER, Véronique et al.European journal of pharmacology. 2006, Vol 550, Num 1-3, pp 149-154, issn 0014-2999, 6 p.Article

Effects of amphetamine, dexfenfluramine, diazepam, and dietary manipulations on responding reinforced by stimuli paired with food in nonhuman primatesFOLTIN, Richard W.Pharmacology, biochemistry and behavior. 2004, Vol 77, Num 3, pp 471-479, issn 0091-3057, 9 p.Article

Comportement alimentaire, régulation pondérale et isoméride, Rouen, 9 juin 1988 = Feeding behavior, weight control and isomeride. Rouen, 9 June 1988DORNER, M; WOLF, L.-M.Annales de médecine interne (Paris). 1989, Vol 140, issn 0003-410X, 24 p., suppl. 1Conference Proceedings

Effects of acute administration of phentermine, alone or in combination with dexfenfluramine, on pain reactivity in the adult ratWELLMAN, P. J.Pharmacology, biochemistry and behavior. 2008, Vol 90, Num 3, pp 339-343, issn 0091-3057, 5 p.Article

Flavor avoidance induced by licl and dexfenfluramine in rats and mice using nondeprivation protocolsROWLAND, Neil E; CANSLER, Kelly; KIM, Emily et al.Behavioral neuroscience. 2002, Vol 116, Num 5, pp 777-784, issn 0735-7044Article

Primary pulmonary hypertension associated with the use of fenfluramine derivativesSIMONNEAU, G; FARTOUKH, M; SITBON, O et al.Chest. 1998, Vol 114, Num 3, pp 195S-199S, issn 0012-3692, SUPConference Paper

A close look at fenfluramine and dexfenfluramineVIVERO, L. E; ANDERSON, P. O; CLARK, R. F et al.The Journal of emergency medicine. 1998, Vol 16, Num 2, pp 197-205, issn 0736-4679Conference Paper

Effects of repeated oral doses of dexnorfenfluramine on 5-HT levels and 5-HT uptake sites in rat brainGOBBI, M; BERGAMI, A; CALTAVUTURO, C et al.Neuroscience letters. 1996, Vol 219, Num 1, pp 5-8, issn 0304-3940Article

Area postrema and the anorectic actions of dexfenfluramine and amylinROWLAND, N. E; RICHMOND, R. M.Brain research. 1999, Vol 820, Num 1-2, pp 86-91, issn 0006-8993Article

Metabolism of dexfenfluramine in human liver microsomes and by recombinant enzymes : role of CYP2D6 and 1A2HARITOS, V. S; CHING, M. S; GHABRIAL, H et al.Pharmacogenetics (London). 1998, Vol 8, Num 5, pp 423-432, issn 0960-314XArticle

Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjectsCOCCARO, E. F; KAVOUSSI, R. J; COOPER, T. B et al.Psychopharmacologia. 1998, Vol 138, Num 1, pp 9-15, issn 0033-3158Article

Pharmacological approaches to interventionGUY-GRAND, B.International journal of obesity. Supplement. 1997, Vol 21, Num 1, pp S22-S24, issn 1359-6373Conference Paper

Efficacy of fenfluramine and dexfenfluramine in the treatment of obesity : A meta-analysisCARVAJAL, A; GARCIA DEL POZO, J; DE DIEGO, I. M et al.Methods and findings in experimental and clinical pharmacology. 2000, Vol 22, Num 5, pp 285-290, issn 0379-0355Article

Impact of antenatal exposure of mice to fenfluramine on cardiac development and long-term growth of the offspringRAYBURN, W. F; SIENKO, A. E; GONZALEZ, C. L et al.Drug and chemical toxicology (New York, NY. 1978). 2000, Vol 23, Num 3, pp 419-431, issn 0148-0545Article

Appetite suppressant valvulopathy : A review of current dataWEISSMAN, N. J.Cardiovascular reviews & reports. 1999, Vol 20, Num 3, pp 146-155, issn 0197-3118, 8 p.Article

Chronic d-fenfluramine treatment reduces fat intake independent of macronutrient preferenceSMITH, B. K; YORK, D. A; BRAY, G. A et al.Pharmacology, biochemistry and behavior. 1998, Vol 60, Num 1, pp 105-114, issn 0091-3057Article

Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramineMCCANN, U. D; ELIGULASHVILI, V; RICAURTE, G. A et al.Progress in neuro-psychopharmacology & biological psychiatry. 1998, Vol 22, Num 7, pp 1087-1102, issn 0278-5846Article

Dexfenfluramine hydrochloride : An anorexigenic agentBEVER, K. A; PERRY, P. J.American journal of health-system pharmacy. 1997, Vol 54, Num 18, pp 2059-2072, issn 1079-2082Article